FARO ECONÓMICOSTOCK ANALYSIS

HIMS — analysis and forecast

$27.71-4.9% todayHims & Hers Health, Inc.
Verdict
Neutral
RSI (14)
43
MACD
▼ falling
Trend
Downtrend
Volatility
80%
52w range
38%

🧬 Faro multibagger DNA

Does it look today like the big multibaggers (×10, ×100) did when they started? 7 traits measured with public data.

80/ 100
Strong multibagger DNA

Strongest: Cash it generates and Price vs. growth. Most lacking: Balance sheet and Faro seal.

Room to grow86

Worth $6.5 B. To grow ×10 it would have to reach $64.7 B.

Sales engine81

Sales +38% last quarter (year over year) and +59% last fiscal year · slowing.

Business quality75

Gross margin 70%, operating margin -13%, return on equity -32%.

Cash it generates100

Free cash flow $849 M a year = 13.1% of its value.

Price vs. growth100

Trades at 2.5× sales: 0.05 per point of growth (lower is better).

Balance sheet44

Net debt equal to 11% of its value.

Faro seal57

No recent federal contracts on the radar · inside a Faro megatrend · insiders own 4.9%.

⏱️ Timing (not scored): mid-range over 12 months (38%) · above its 200-day average · trailing the S&P 500 by 53 points over 12 months.

Built on the traits of 365 stocks that went ×100 (Mayer, 1962–2014) and 464 that went ×10 (Yartseva, 2009–2024), plus the Faro thesis. It does not predict the price and is not a recommendation. How it works and the ranking →

🔢 What the numbers say

The last 12 months, in plain words

🗓️ Forecast by horizon

Directional bias · probability of rising · expected price and likely range (68%)

HorizonBiasProb. upExpected price68% range
1 dayBearish46%$27.72 +0.1%$26.37 – $29.15
3 daysBearish45%$27.75 +0.2%$25.44 – $30.27
1 weekBearish46%$27.78 +0.3%$24.83 – $31.08
15 daysNeutral47%$27.85 +0.5%$23.76 – $32.64
1 monthNeutral47%$28.01 +1.1%$22.25 – $35.25
3 monthsNeutral48%$28.61 +3.2%$19.21 – $42.60

Recent momentum: -5.8% over 20 days · +2.5% over 60 days. The further out the horizon, the wider and more uncertain the forecast.

📈 Probability cone

📜 Government contracts

We have no notable federal contract on file for HIMS. You can look it up yourself at USASpending.gov or in the Government Sources hub.

📚 Go deeper: Faro Library reports

PDF reports built from official filings. Your first one is free, no email; then $1.99 each or all 30 for $25 — included in Navigator and Admiral.

See all 30 reports →

❓ Frequently asked questions about HIMS

Could HIMS be the next NVIDIA?

Its Faro multibagger DNA is 80/100 (strong multibagger dna): it measures how much it looks today like the big multibaggers did when they started (size, sales growth, quality, cash, price versus growth, balance sheet and public contracts). To grow ×10 it would need to be worth about 10 times today's value. Not a prediction or a recommendation.

How much has HIMS fallen in the last year?

Hims & Hers Health (HIMS) is down 41.6% over the last 12 months and trades at $27.71, 43.2% below its 52-week high ($48.78). 52-week range: $14.52 – $48.78.

How volatile is HIMS stock?

Its annualized volatility is around 80% and its worst drop from a peak over the last year was 70.2%. For reference, the S&P 500 usually moves 15–20% a year.

Does HIMS have U.S. government contracts?

There is no notable federal contract in Faro's register. You can search USASpending.gov.

Is now a good time to buy HIMS?

Nobody can know that for sure and this page is not a buy recommendation. What the data shows today: neutral technical bias, RSI 43, price below its 50-day average and an estimated 47% probability of being higher in 1 month. Use it as a starting point for research, not as a signal.

🧠 How it is calculated

The verdict combines trend (20/50/200 moving averages), momentum (RSI, MACD), mean reversion (Bollinger Bands), conviction (volume) and historical drift, weighted differently for each horizon. Uncertainty is modeled with a lognormal probability cone (geometric Brownian motion). This is statistical analysis, not a crystal ball.

🔦 Keep analyzing

Other stocks Faro watches

🔮 Oracle Pro 📈 Trading Room 📅 Calendar

⚠️ Educational tool. Not financial advice. Forecasts are statistical estimates based on historical volatility; the market can do the opposite. Data via Yahoo Finance. Always verify before trading. The decisions are yours.